10 biotechs become 1: Centessa launches with $250M to prove unorthodox R&D model
Bio Pharma Dive
FEBRUARY 16, 2021
The new company will be led by Saurabh Saha, a former Bristol Myers executive, and Moncef Slaoui, who until recently led the U.S. government's coronavirus vaccine program.
Let's personalize your content